Product Information
FLUVOXAMINE MALEATE 100 MG TAB is a generic product labeled by Bionpharma Inc., priced at $0.2448 per EA under NDC 69452045520. Its NADAC has been published 53 times since Oct 1, 2025.
FDA first approved this application on Jan 22, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Bionpharma Inc.NDC
69452045520
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUVOXAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA217917FDA Approved
1/22/2024
TE Code
AB
On Market Since
2/7/2025
Pharmacological Classes
Price Statistics
The NADAC for FLUVOXAMINE MALEATE 100 MG TAB has been published 53 times since Oct 1, 2025, and over the history we have for it it has declined 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2448 per EA |
|---|---|
| All-time high | $0.2711 (Jan 14, 2026) |
| All-time low | $0.2436 (Jul 22, 2026) |
| 52-week high | $0.2711 |
| 52-week low | $0.2436 |
| Median price | $0.2513 |
| Average price | $0.2551 |
| Largest weekly change | -2.9% (Mar 18, 2026) |
| Weeks tracked | 53 |
| Tracking since | Oct 1, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluvoxamine maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUVOXAMINE MALEATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FLUVOXAMINE MALEATE 100 MG TAB, manufactured by Bionpharma Inc., is $0.2448 per EA (NDC 69452045520), effective Sep 30, 2026.
How has the price of FLUVOXAMINE MALEATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for FLUVOXAMINE MALEATE 100 MG TAB has declined 6.0%. It has been tracked across 53 weekly CMS publications since Oct 1, 2025.
What are the highest and lowest recorded NADAC prices for FLUVOXAMINE MALEATE 100 MG TAB?
Since Oct 1, 2025, the NADAC for FLUVOXAMINE MALEATE 100 MG TAB has ranged from a low of $0.2436 (Jul 22, 2026) to a high of $0.2711 (Jan 14, 2026), with a median of $0.2513 per EA.
Are there cheaper alternatives to FLUVOXAMINE MALEATE 100 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUVOXAMINE MALEATE 100 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUVOXAMINE MALEATE 100 MG TAB?
FLUVOXAMINE MALEATE 100 MG TAB (NDC 69452045520) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.